Skip to main content

Month: February 2024

Cronos Group Reports 2023 Fourth Quarter and Full-Year Results¹

Ended 2023 with approximately $862 million in cash and short-term investments Commenced sales to Australian partner Launched award-winning Lord Jones® brand in Canada Consolidated net revenue increased 9% in Q4 2023 compared to Q4 2022; on a constant currency basis consolidated net revenue increased 11% in Q4 2023 compared to Q4 2022 Net revenue in Canada increased 20% in Q4 2023 compared to Q4 2022; on a constant currency basis net revenue in Canada increased 21% in Q4 2023 compared to Q4 2022 TORONTO, Feb. 29, 2024 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announces its 2023 fourth quarter and full-year business results1. “In 2023, we significantly improved our cash flow from operations driven primarily by operating expense savings, while simultaneously expanding our portfolio...

Continue reading

Studio City International Holdings Limited Announces Unaudited Fourth Quarter 2023 Earnings

MACAU, Feb. 29, 2024 (GLOBE NEWSWIRE) — Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a world-class integrated resort located in Cotai, Macau, today reported its unaudited financial results for the fourth quarter and full year ended December 31, 2023. Total operating revenues for the fourth quarter of 2023 were US$141.3 million, compared with total operating revenues of US$4.2 million in the fourth quarter of 2022. The change was primarily attributable to the relaxation of COVID-19 related restrictions in Macau in January 2023 and the opening of Studio City Phase 2, which led to an increase in revenue from casino contract and higher non-gaming revenues. Studio City Casino generated gross gaming revenues of US$294.8 million and US$40.9 million for the fourth quarters of 2023 and 2022, respectively. Studio...

Continue reading

Codere Online Reports Financial Results for the Fourth Quarter and Full Year 2023

Total revenue was €46.9 mm in Q4 2023, while net gaming revenue1 was €50.1 mm in the period, 32% and 33% above those from Q4 2022, respectively. Mexico revenue was €22.6 mm in Q4 2023, while net gaming revenue1 was €25.1 mm in the period, 54% above Q4 2022. Spain revenue (and net gaming revenue) reached €20.8 mm in Q4 2023, 17% above Q4 2022. Net loss was €1.0 mm in Q4 2023 versus a net loss of €17.4 mm in Q4 2022. Total cash position of €41 mm as of December 31, 2023.Providing full year 2024 net gaming revenue outlook of €185-200 mm and expect to generate positive Adjusted. EBITDA and cash flow.Madrid, Spain and Tel Aviv, Israel, February 29, 2024 – (GLOBE NEWSWIRE) Codere Online (Nasdaq: CDRO / CDROW, the “Company”), a leading online gaming operator in Spain and Latin America, has released its preliminary unaudited2 financial...

Continue reading

Melco Announces Unaudited Fourth Quarter 2023 Earnings

MACAU, Feb. 29, 2024 (GLOBE NEWSWIRE) — Melco Resorts & Entertainment Limited (Nasdaq: MLCO) (“Melco” or the “Company”), a developer, owner, and operator of integrated resort facilities in Asia and Europe, today reported its unaudited financial results for the fourth quarter and full year ended December 31, 2023. Total operating revenues for the fourth quarter of 2023 were US$1.09 billion, representing an increase of approximately 224% from US$337.1 million for the comparable period in 2022. The increase in total operating revenues was primarily attributable to the improved performance in all gaming segments and non-gaming operations following the relaxation of COVID-19 related restrictions in Macau in January 2023 and the opening of Studio City Phase 2. Operating loss for the fourth quarter of 2023 was US$94.4 million, compared...

Continue reading

Uniti Group Inc. Reports Fourth Quarter and Full Year 2023 Results

Recently Announced ABS Bridge Financing & Asset Sales Further Strengthen Balance Sheet Provides Initial 2024 OutlookNet Income (Loss) of $30.7 Million and ($81.7) Million for the Fourth Quarter and Full Year, Respectively Net Income (Loss) of $0.13 and ($0.35) Per Diluted Common Share for the Fourth Quarter and Full Year, Respectively AFFO Per Diluted Common Share of $0.34 and $1.42 for the Fourth Quarter and Full Year, RespectivelyLITTLE ROCK, Ark., Feb. 29, 2024 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti” or the “Company”) (Nasdaq: UNIT) today announced its results for the fourth quarter and full year 2023. “2023 was another productive year for Uniti. Our core recurring strategic fiber business continues to demonstrate its resiliency with top line growth of 5% in 2023 when compared to 2022 and continued declining net...

Continue reading

Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results

— Record revenues of $675 million in 2023 — — Full-year GAAP net income of $42 million and adjusted EBITDA of $214 million — — EXPAREL surpasses the 14 million patient mark — — Conference call today at 8:30 a.m. ET — TAMPA, Fla., Feb. 29, 2024 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported financial results for the fourth quarter and full-year of 2023. “Now that I have spent several weeks working with the Pacira team, I am even more enthusiastic to lead this great company as we build upon an impressive foundation of success,” said Frank D. Lee, chief executive officer of Pacira BioSciences. “Looking ahead, we are sharply focused on driving long-term growth, furthering our patient centric culture and...

Continue reading

Clinical Study Results Involving Spryng, a PetVivo Holdings, Inc. Product, Presented at the Veterinary Orthopedic Society Annual Conference in Lake Tahoe, California

MINNEAPOLIS, MN, US, Feb. 29, 2024 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the “Company” or “PetVivo”) an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals announced that Alexander Amalfitano DVM, of Ethos Veterinary Health and Colorado Animal Specialty & Emergency (CASE) presented at the Veterinary Orthopedic Society (“VOS”) annual conference on the completion of the first cohort of dogs in a clinical study, which examined the benefit and tolerability of an intra-articular injection of collagen-elastin hydrogel microparticles (i.e. Spryng™ with OsteoCuhsion™ Technology) into the coxofemoral joint of dogs with osteoarthritis. “We were pleased to have Dr. Amalfitano present the Spryng clinical...

Continue reading

NV5 Awarded $5 Million Infrastructure Mapping Services Contract by City of San Diego

HOLLYWOOD, Fla., Feb. 29, 2024 (GLOBE NEWSWIRE) — NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of technology, conformity assessment, and consulting solutions, announced today that it has been awarded a three-year, $5 million contract by the City of San Diego to provide land surveying, mapping, and digitizing services to support municipal infrastructure projects throughout the city. NV5 surveyors and geospatial professionals will deliver services for a wide array of infrastructure projects including water, wastewater, storm water pipelines, buildings, bridges, roadways, facilities, and parks. This is the second time NV5 has been awarded this contract by the City of San Diego, and NV5 is currently delivering services under this new agreement. “We have contributed to infrastructure improvements in the City...

Continue reading

Bionano to Present at TD Cowen’s 44th Annual Health Care Conference

SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at TD Cowen’s 44th Annual Health Care Conference on March 6, 2024. Conference & Webcast DetailsDate: Wednesday, March 6th, 2024Time: 12:50 p.m. to 1:20 p.m. ETPresenter: Erik Holmlin, PhD, CEO of BionanoWebcast: Link to RegisterA replay / recording of the session will be available following the conference through the Bionano website at https://ir.bionano.com/ for at least 30 days. About Bionano Bionano is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. Bionano’s mission is to transform the way the world sees the genome through...

Continue reading

Auddia Details Expected Synergies of Proposed Acquisition of Radio FM

Acquired ad revenue growth expected from improving ad market rates and optimization of programmatic CPMs Near term integration of Auddia’s AI into the Radio FM (RFM) app delivers a premium ad-free AM/FM listening experience for existing users who elect to subscribe Near term integration of Auddia’s AI into the RFM app provides Auddia ad-free podcast partners access to global user base BOULDER, CO, Feb. 29, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – Auddia Inc. (NASDAQ:AUUD) (NASDAQ:AUUDW) (“Auddia” or the “Company”), a proprietary AI platform for audio identification and classification and related technologies, that is reinventing how consumers engage with AM/FM radio, podcasts, and other audio content, detailed today how the company expects to drive significant synergies through its proposed acquisition...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.